141 – 150 of 200
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation
- Contribution to journal › Article
-
Mark
Neuroinflammation in the generation of post-transplantation dyskinesia in Parkinson's disease.
- Contribution to journal › Article
-
Mark
Two routes for L-dopa to be converted to dopamine
(2008) 15th Annual Meeting of the American Society for Neural Therapy and Repair In Cell Transplantation 17(4). p.482-482
- Contribution to journal › Published meeting abstract
- 2007
-
Mark
Spatiotemporal pattern of striatal ERK1/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptors
- Contribution to journal › Article
-
Mark
Modulation of l-DOPA-induced abnormal involuntary movements by clinically tested compounds: Further validation of the rat dyskinesia model.
- Contribution to journal › Scientific review
-
Mark
Animal models of neurodegenerative disease: Insights from in vivo imaging studies
- Contribution to journal › Scientific review
-
Mark
The "motor complication syndrome" in rats with 6-OHDA lesions treated chronically with l-DOPA: Relation to dose and route of administration.
- Contribution to journal › Article
-
Mark
Congo red and protein aggregation in neurodegenerative diseases
- Contribution to journal › Article
-
Mark
Proteomic analysis of striatal proteins in the rat model of l-DOPA-induced dyskinesia.
- Contribution to journal › Article
-
Mark
Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease.
- Contribution to journal › Article
